Related Experiment Video
Updated: Oct 6, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.
Ruth Ann Marrie1, Gary R Cutter2, Robert J Fox3
1Department of Internal Medicine and Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada (RAM).
International Journal of MS Care
|January 17, 2022
Summary
Patient registries like NARCOMS are vital for understanding multiple sclerosis (MS) progression and treatment outcomes. These data sources inform clinical care and health policy for individuals with MS.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Observational studies and registries are crucial for understanding the natural and treated history of multiple sclerosis (MS).
- Identifying factors influencing disability and quality of life in MS patients is essential for effective management.
- The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a significant patient-driven data source.
Purpose of the Study:
- To highlight the importance of disease registries in the field of multiple sclerosis.
- To discuss key concepts in the design and management of patient registries.
- To present findings from MS registries relevant to clinical practice and health policy.
Main Methods:
- Review of the role and impact of disease registries in multiple sclerosis research.
- Discussion of principles for effective registry design and data management.
- Synthesis of findings from existing MS registries.
Main Results:
- Disease registries provide critical insights into the long-term outcomes of multiple sclerosis.
- Patient-driven registries, like NARCOMS, offer unique perspectives on living with MS.
- Registry data can inform evidence-based clinical care and influence health policy decisions.
Conclusions:
- Multiple sclerosis registries are indispensable tools for advancing research and improving patient care.
- Effective registry design and management are key to generating reliable and actionable data.
- Findings from MS registries have direct implications for clinical practice and health policy.

